SMTL ID : 5mw3.2 (1 other biounit)

Crystal structure of Dot1L in complex with inhibitor CPD1 [N6-(2,6-dichlorophenyl)-N6-(pent-2-yn-1-yl)quinoline-4,6-diamine] and inhibitor CPD2 [(R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine]

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.09 Å
Oligo State
monomer
Ligands
1 x 5JJ: N~6~-(2,6-dichlorophenyl)-N~6~-(pent-2-yn-1-yl)quinoline-4,6-diamine(Non-covalent)
1 x 5JT: (3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Mobitz, H. et al., Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach. ACS Med Chem Lett (2017)
Release Date
2017-03-22
Peptides
Histone-lysine N-methyltransferase, H3 lysine-79 specific: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
B

Histone-lysine N-methyltransferase, H3 lysine-79 specific

Related Entries With Identical Sequence

5drt.1 | 5drt.2 | 5dry.1 | 5dry.2 | 5dsx.1 | 5dsx.2 | 5dt2.1 | 5dt2.2 | 5dtm.1 | 5dtm.2 | 5dtq.1 | 5dtq.2 | 5dtr.1 | 5dtr.2 | 5mvs.1 | 5mw3.1 | 5mw4.1 | 5mw4.2 | 6te6.1 | 6te6.2 | 6tel.1 | 6tel.2 | 6ten.1 | 6ten.2